Geftinat Tab

Product Description

Geftib 250mg tablet is used to treat adults with non-small cell lung cancer (locally advanced or distance spread metastasis).

How it works 

Geftib 250mg tablet blocks a protein called epidermal growth factor receptor (EGFR) which is involved in the growth and spread of cancer cells.

Common side effects 

Nausea, Pancreatic inflammation, Liver inflammation, Bleeding, Dehydration, Diarrhoea, Difficulty in urination, Lung disorder, Fever, Hair loss, Increased bilirubin in the blood, Liver enzyme increased, Increased creatinine level in blood, Itching, Dry skin, Loss of appetite, Nail disorder, Eye redness, Eye itching, Sore eyelids, Eyelid redness, Skin reaction, Mouth ulcer, Skin redness, Vomiting, Weakness.